William F. Doyle

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
7 years
Director since
2023

7 years of board service in total across 3 boards, counting each seat separately. Longest: ProKidney Corp., 3 years.

ProKidney Corp. Director
3 years · Since 2023
2 years · Since 2023
NovoCure Limited Director · Executive Chairman
8 months · Since 2026

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Mar 3, 2026 NovoCure Limited Grant or award +200,000 — —
Mar 3, 2026 NovoCure Limited Grant or award +200,284 — —
Mar 3, 2026 NovoCure Limited Open-market sale −50,557 $12.79 $646,624
Mar 3, 2026 NovoCure Limited Open-market sale −21,330 $13.43 $286,462
Nov 29, 2024 Elanco Animal Health Incorporated Grant or award +18,169 — —
May 21, 2024 Elanco Animal Health Incorporated Open-market purchase +15,000 $16.98 $254,700
Mar 8, 2024 Elanco Animal Health Incorporated Open-market purchase +15,000 $16.30 $244,500
Nov 30, 2023 Elanco Animal Health Incorporated Grant or award +20,374 — —

Questions about William F. Doyle

What boards is William F. Doyle on?

William F. Doyle sits on the boards of Elanco Animal Health Incorporated, NovoCure Limited and ProKidney Corp.

How long has William F. Doyle served on boards?

Our records show at least 7 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.